Related Experiment Videos

Interaction of immunomodulant substances in mouse experiments with special regard to drug sensitivity and bacterial

P Anderlik1, I Szeri, K Antmann

  • 1Institute of Microbiology, Semmelweis University Medical School, Budapest, Hungary.

Insights

Combined immunosuppressive drugs (dianhydrogalactitol and chlorpromazine) increased mouse sensitivity and bacterial translocation (BT). Immunostimulatory Mannozym had no effect. This suggests cumulative damage from combined immunosuppressants.

Area of Science:

  • Immunopharmacology
  • Toxicology
  • Microbiology

Background:

  • Immunomodulatory drugs can alter host defense mechanisms.
  • Bacterial translocation (BT) is a marker of gut barrier integrity.
  • Understanding drug interactions is crucial for managing toxicity.

Purpose of the Study:

  • To investigate the effects of combined immunomodulatory drugs on drug sensitivity and bacterial translocation (BT) in mice.
  • To evaluate the impact of dianhydrogalactitol (DAG), chlorpromazine (CPZ), and Mannozym (M) on acute toxicity.

Main Methods:

  • Acute toxicity experiments were conducted in mice.
  • Mice were treated with DAG, CPZ, or Mannozym, alone or in combination.
  • Drug sensitivity and the rate of bacterial translocation (BT) were measured.

Main Results:

  • Combined treatment with immunosuppressive DAG or CPZ significantly increased mouse sensitivity compared to separate treatments.
  • The rate of bacterial translocation (BT) was also elevated in mice receiving combined immunosuppressive drugs.
  • Immunostimulatory Mannozym did not affect drug sensitivity or BT rates.

Conclusions:

  • The cumulative effects of immunosuppressive drugs can lead to more severe organismal damage.
  • Increased drug sensitivity to immunosuppressive agents may be linked to elevated BT and endotoxin effects.
  • Immunostimulatory agents like Mannozym may not mitigate the risks associated with combined immunosuppressants.

Related Concept Videos